Skip to content

The chronic treatments of PDE-5 inhibitors in ED patients improve testosterone levels and oxdative status: the comparison of Sidenafil with Tadalafil.

The chronic treatments of PDE-5 inhibitors in ED patients improve testosterone levels and oxdative status: the comparison of Sidenafil with Tadalafil. - Tadalafil improves testosterone levels and decreases oxdative stress defined by salivary 8-OHdG.

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000000986
Enrollment
60
Registered
2008-01-30
Start date
2008-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile and endothelial dysfunction are common pathologies of multiple cardiovascular risk factors and are considered longitudinal predictors of cardiovascular events. Oxidative stress and decreases in testosterone levels play an important role in the pathogenesis of endothelial dysfunction.

Interventions

Regular intake of Sildenafil 50mg once a week Regular intake of Tadanafil 20mg once a week

Sponsors

Teikyo University, School of Medicine, Department of Urology
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: ED patients whose IIEF-scores are less than 17.Inclusion criteria included married with stable sexual relations with a female partner for at least 6 months before the study, as well as no previous treatment for ED.

Exclusion criteria

Exclusion criteria: Subjects with kidney disease, liver failure, coronary heart disease, peripheral or cerebrovascular disease, endocrine diseases, prostatic disease, and major psychiatric disorders, except depression, were excluded. Patients concomitantly treated with nitrates or with congestive heart failure or those who were prescribed medicines that might modulate testosterone metabolism were also excluded.

Design outcomes

Primary

MeasureTime frame
IIEF-EF scores are used to assess ED severity. Antioxidant status is defined by salivary 8-OHdG. Salivary testosterone is used to evaluate serum bioavailable testosterone availability.

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026